Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,987.37
+18.03(+0.30%)
Dow 30
44,736.57
+440.06(+0.99%)
Nasdaq
19,054.84
+51.19(+0.27%)
Russell 2000
2,442.03
+35.36(+1.47%)
Crude Oil
68.67
-0.27(-0.39%)
Gold
2,612.50
-6.00(-0.23%)

Inspire Medical Systems, Inc. (INSP)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

199.32

+10.59

(+5.61%)

At close: 04:00PM EST

199.32

0.00

(0.00%)

After hours:

06:14PM EST

Ticker Change
INSP is trading under new symbol AVTA effective Jan. 26, 2023

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	5.66B
Enterprise Value	5.27B
Trailing P/E	170.03
Forward P/E	102.04
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	7.57
Price/Book (mrq)	8.12
Enterprise Value/Revenue	6.97
Enterprise Value/EBITDA	136.00

Trading Information

Stock Price History

Beta (5Y Monthly)	1.36
52-Week Change ³	30.68%
S&P500 52-Week Change ³	31.18%
52 Week High ³	257.40
52 Week Low ³	123.00
50-Day Moving Average ³	199.53
200-Day Moving Average ³	186.44

Share Statistics

Avg Vol (3 month) ³	595.91k
Avg Vol (10 day) ³	548.24k
Shares Outstanding ⁵	29.97M
Implied Shares Outstanding ⁶	29.97M
Float ⁸	29.42M
% Held by Insiders ¹	1.95%
% Held by Institutions ¹	113.91%
Shares Short (Oct 31, 2024) ⁴	1.95M
Short Ratio (Oct 31, 2024) ⁴	5.07
Short % of Float (Oct 31, 2024) ⁴	7.48%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	6.52%
Shares Short (prior month Sep 30, 2024) ⁴	2M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	4.37%
Operating Margin (ttm)	7.05%

Management Effectiveness

Return on Assets (ttm)	1.17%
Return on Equity (ttm)	5.33%

Income Statement

Revenue (ttm)	755.59M
Revenue Per Share (ttm)	25.45
Quarterly Revenue Growth (yoy)	32.50%
Gross Profit (ttm)	N/A
EBITDA	18.39M
Net Income Avi to Common (ttm)	33.05M
Diluted EPS (ttm)	1.18
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	410.99M
Total Cash Per Share (mrq)	13.72
Total Debt (mrq)	25.33M
Total Debt/Equity (mrq)	3.64%
Current Ratio (mrq)	7.84
Book Value Per Share (mrq)	23.25

Cash Flow Statement

Operating Cash Flow (ttm)	78.33M
Levered Free Cash Flow (ttm)	21.27M